Barrow, Hanley, Mewhinney & Strauss’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-56
Closed -$497 361
2025
Q1
$497 Buy
+56
New +$497 ﹤0.01% 317